SI-BONE, INC. Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value
SI-BONE, INC. (SIBN) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value of $8.16 per share for the 12-month period ending 2020-12-31, per its 10-K filed 2021-03-10.
Discontinued › Notes › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue · last filed 2021-11-09
- SI-BONE, INC. share-based compensation arrangement by share-based payment award, options, grants in period, weighted average grant date fair value for the quarter ending 2020-03-31 was $8.37, a 19.52% decline year-over-year.
- SI-BONE, INC. share-based compensation arrangement by share-based payment award, options, grants in period, weighted average grant date fair value for the quarter ending 2019-09-30 was $5.43, a 56.03% increase year-over-year.
- SI-BONE, INC. share-based compensation arrangement by share-based payment award, options, grants in period, weighted average grant date fair value for the quarter ending 2019-06-30 was $8.00, a 279.15% increase year-over-year.
- SI-BONE, INC. share-based compensation arrangement by share-based payment award, options, grants in period, weighted average grant date fair value for the quarter ending 2019-03-31 was $10.40, a 388.26% increase year-over-year.
- SI-BONE, INC. share-based compensation arrangement by share-based payment award, options, grants in period, weighted average grant date fair value for fiscal 2020 was $8.16, a 16.56% decline from fiscal 2019.
- SI-BONE, INC. share-based compensation arrangement by share-based payment award, options, grants in period, weighted average grant date fair value for fiscal 2019 was $9.78, a 145.73% increase from fiscal 2018.
- SI-BONE, INC. share-based compensation arrangement by share-based payment award, options, grants in period, weighted average grant date fair value for fiscal 2018 was $3.98, a 121.11% increase from fiscal 2017.
- SI-BONE, INC. share-based compensation arrangement by share-based payment award, options, grants in period, weighted average grant date fair value for fiscal 2017 was $1.80.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value 12 month |
|---|---|---|---|---|
| 2020-12-31 | $8.16 10-K · filed 2021-03-10 | |||
| 2020-09-30 | $8.37 10-Q · filed 2021-11-09 | |||
| 2020-06-30 | $8.37 10-Q · filed 2021-08-04 | |||
| 2020-03-31 | $8.37 10-Q · filed 2021-05-04 | |||
| 2019-12-31 | $9.78 10-K · filed 2021-03-10 | |||
| 2019-09-30 | $5.43 10-Q · filed 2020-11-03 | $9.78 10-Q · filed 2020-11-03 | ||
| 2019-06-30 | $8.00 10-Q · filed 2020-08-04 | $9.79 10-Q · filed 2020-08-04 | ||
| 2019-03-31 | $10.40 10-Q · filed 2020-05-05 | |||
| 2018-12-31 | $3.98 10-K · filed 2020-03-11 | |||
| 2018-09-30 | $3.48 10-Q · filed 2019-11-12 | $2.47 10-Q · filed 2019-11-12 | ||
| 2018-06-30 | $2.11 10-Q · filed 2019-08-07 | $2.09 10-Q · filed 2019-08-07 | ||
| 2018-03-31 | $2.13 10-Q · filed 2019-05-09 | |||
| 2017-12-31 | $1.80 10-K · filed 2019-03-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SpyGlass Pharma, Inc. (SGP) | United States | $0.925B | |
| MIMEDX GROUP, INC. (MDXG) | United States | $0.687B | 89.92 |
| Beta Bionics, Inc. (BBNX) | United States | $0.979B | -9.66 |
| PROCEPT BioRobotics Corp (PRCT) | United States | $1.001B | -11.77 |
| ANGIODYNAMICS INC (ANGO) | United States | $0.632B | -13.02 |
| TANDEM DIABETES CARE INC (TNDM) | United States | $1.059B | -16.57 |
| ORTHOPEDIATRICS CORP (KIDS) | United States | $0.592B | |
| SS Innovations International, Inc. (SSII) | $0.589B | -64.06 | |
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| DELCATH SYSTEMS, INC. (DCTH) | United States | $0.558B | 820.33 |